Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA4 | P22459 | 1/20 | 0.34 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.34 |
| ▸ | KCNAB1 | Q14722 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18840307 | 0.94 | KCNA4 (0.34) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL16487796 | 0.92 | KCNA4 (0.33) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL13897196 | 0.88 | KCNA4 (0.37) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL1471940 | 0.81 | KCNA4 (0.40) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL10549603 | 0.73 | KCNA4 (0.36) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL23906174 | 0.72 | — | — | |
| SCHEMBL13208899 | 0.71 | KCNA4 (0.34) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL19031910 | 0.69 | KCNA4 (0.33) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL3265548 | 0.67 | KCNA4 (0.40) | KCNA4KCNA1KCNAB1 | |
| SCHEMBL657969 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | MURATA MANUFACTURING CO., LTD. (JP) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210226253-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM-ION SECONDARY BATTERY, AND LITHIUM-ION SECONDARY BATTERY | TPO, DNASE1, KCNN2 | KCNA4 796/4885KCNA1 281/4885KCNAB1 267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.